Evan Roberts Sells 10,716 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 10,716 shares of the business’s stock in a transaction dated Monday, January 27th. The stock was sold at an average price of $27.48, for a total transaction of $294,475.68. Following the transaction, the chief operating officer now owns 764,307 shares in the company, valued at approximately $21,003,156.36. The trade was a 1.38 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total value of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The stock was sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $76,450.53.

Phreesia Trading Up 1.1 %

NYSE:PHR opened at $29.03 on Friday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $29.90. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of -19.75 and a beta of 0.94. The business’s 50-day moving average price is $24.78 and its two-hundred day moving average price is $23.24.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. Phreesia’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same period last year, the company posted ($0.58) EPS. On average, equities analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on PHR shares. JMP Securities reiterated a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Citigroup increased their target price on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and increased their price objective for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Truist Financial boosted their target price on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Finally, KeyCorp boosted their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, January 8th. Thirteen equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia has an average rating of “Buy” and a consensus target price of $31.15.

Hedge Funds Weigh In On Phreesia

Several institutional investors and hedge funds have recently made changes to their positions in the company. Champlain Investment Partners LLC raised its stake in Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after buying an additional 97,847 shares during the period. Sei Investments Co. raised its position in shares of Phreesia by 135.3% during the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after purchasing an additional 95,058 shares during the period. Squarepoint Ops LLC lifted its holdings in shares of Phreesia by 56.3% during the 2nd quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock valued at $5,308,000 after purchasing an additional 90,215 shares in the last quarter. State Street Corp grew its position in shares of Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares during the period. Finally, Geode Capital Management LLC increased its stake in Phreesia by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after purchasing an additional 55,934 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.